返回
M
Mohammad‐Taghi Golmakani
Shiraz University
37H指数
306论文数
4.9K被引数
收录论文 93
发表时间
Phase Ib/II first-in-class novel combination trial of next generation CDK4-selective inhibitor PF-07220060 and next generation CDK2-selective inhibitor PF-07104091 in HR+HER2-metastatic breast cancer and advanced solid tumorsIb/II期首创性新型组合试验,研究下一代CDK4选择性抑制剂PF-07220060与下一代CDK2选择性抑制剂PF-07104091在HR⁺/HER2⁻转移性乳腺癌和晚期实体瘤中的应用。
ANNALS OF ONCOLOGY
IF65.4

